Ortho Clinical Diagnostics received the FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2) for use on the VITROS® 5600 Integrated and VITROS® 3600 Immunodiagnostic Systems. This is the first HIV diagnostic assay approved for an integrated system in the US, allowing laboratories to run HIV and other routine tests on a single testing platform and eliminating the need for expensive batch testing of multiple patient samples.

 Obetech, LLC has developed a diagnostic test for those who have been infected with a particular common cold virus, human Adenovirus 36 (Ad-36). Ad-36 is rapidly gaining recognition as “the obesity virus,” and has been shown to trigger proliferation of fat cells, which ultimately leads to obesity in the infected person. Currently, Obetech offers a diagnostic test which checks for Ad-36 antibodies in the blood. By confirming an individual has been infected with Ad-36, the test can help them predict future weight problems and/or explain unexpected weight gain.